CAD 0.57
(1.79%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 45 Thousand CAD | -120.43% |
2022 | 2.09 Million CAD | 159.18% |
2021 | 598 Thousand CAD | -78.78% |
2020 | 2.26 Million CAD | -29.72% |
2019 | 5.58 Million CAD | 240.44% |
2018 | 2.39 Million CAD | 133.72% |
2017 | -9.65 Million CAD | 64.61% |
2016 | -14.42 Million CAD | 8.46% |
2015 | -7.38 Million CAD | -16.29% |
2014 | -14.24 Million CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -740 Thousand CAD | -183.64% |
2024 Q1 | -346 Thousand CAD | -180.45% |
2023 Q4 | 266 Thousand CAD | 130.16% |
2023 FY | - CAD | -120.43% |
2023 Q3 | -882 Thousand CAD | -421.9% |
2023 Q2 | 274 Thousand CAD | -45.96% |
2023 Q1 | 507 Thousand CAD | -50.0% |
2022 Q1 | 24 Thousand CAD | -98.42% |
2022 FY | - CAD | 159.18% |
2022 Q4 | 1.01 Million CAD | 77.58% |
2022 Q3 | 571 Thousand CAD | -3.87% |
2022 Q2 | 594 Thousand CAD | 2375.0% |
2021 FY | - CAD | -78.78% |
2021 Q3 | -474 Thousand CAD | -64.58% |
2021 Q4 | 1.51 Million CAD | 420.25% |
2021 Q1 | 94 Thousand CAD | 123.62% |
2021 Q2 | -288 Thousand CAD | -406.38% |
2020 Q4 | -398 Thousand CAD | -107.94% |
2020 Q2 | -749 Thousand CAD | -627.46% |
2020 FY | - CAD | -29.72% |
2020 Q1 | 142 Thousand CAD | 136.67% |
2020 Q3 | 5.01 Million CAD | 768.89% |
2019 Q3 | 969 Thousand CAD | -74.58% |
2019 Q4 | 60 Thousand CAD | -93.81% |
2019 FY | - CAD | 240.44% |
2019 Q1 | 858 Thousand CAD | -48.81% |
2019 Q2 | 3.81 Million CAD | 344.29% |
2018 Q3 | 826 Thousand CAD | 497.12% |
2018 Q4 | 1.67 Million CAD | 102.91% |
2018 Q1 | 30 Thousand CAD | 101.48% |
2018 FY | - CAD | 133.72% |
2018 Q2 | -208 Thousand CAD | -793.33% |
2017 Q1 | -2.73 Million CAD | 39.04% |
2017 Q4 | -2.03 Million CAD | -92.24% |
2017 FY | - CAD | 64.61% |
2017 Q3 | -1.05 Million CAD | -222.76% |
2017 Q2 | 861 Thousand CAD | 131.47% |
2016 Q2 | -3.02 Million CAD | 46.49% |
2016 FY | - CAD | 8.46% |
2016 Q4 | -4.48 Million CAD | -66.35% |
2016 Q1 | -5.64 Million CAD | 45.72% |
2016 Q3 | -2.69 Million CAD | 10.75% |
2015 Q4 | -10.4 Million CAD | -369.42% |
2015 Q2 | -5.43 Million CAD | -141.49% |
2015 Q3 | -2.21 Million CAD | 59.18% |
2015 FY | - CAD | -16.29% |
2015 Q1 | -2.24 Million CAD | 0.0% |
2014 FY | - CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aurora Cannabis Inc. | 20.47 Million CAD | 99.78% |
Avicanna Inc. | -7.35 Million CAD | 100.612% |
Avant Brands Inc. | 4.83 Million CAD | 99.069% |
Cardiol Therapeutics Inc. | -27.87 Million CAD | 100.161% |
Knight Therapeutics Inc. | 40.89 Million CAD | 99.89% |
MediPharm Labs Corp. | -10.47 Million CAD | 100.429% |
OrganiGram Holdings Inc. | -207.61 Million CAD | 100.022% |
Canopy Growth Corporation | -312.82 Million CAD | 100.014% |
Willow Biosciences Inc. | -11.06 Million CAD | 100.407% |
Auxly Cannabis Group Inc. | -10.82 Million CAD | 100.416% |